ATH434
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ATH434, covering 2024-12-13 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Post-Trial Access to ATH434 for Patients With Multiple System Atrophy